| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000104 | Succinate dehydrogenase activity | Decreases phenotype | PMID:25245570 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:35547012; PMID:36849043; PMID:39177155 |
| GO:0001541 | Ovarian follicle development | Increases phenotype | PMID:26348139 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:23470461; PMID:23470461; PMID:25568306; PMID:26348139 |
| GO:0001916 | Positive regulation of t cell mediated cytotoxicity | Decreases phenotype | PMID:28899767 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:30974164; PMID:36880428 |
| GO:0003876 | Amp deaminase activity | Increases phenotype | PMID:29665407 |
| GO:0003954 | Nadh dehydrogenase activity | Decreases phenotype | PMID:25245570 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:28988497 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:28988497 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:28988497; PMID:28988497; PMID:30974164; PMID:31756458 |
| GO:0004096 | Catalase activity | Increases phenotype | PMID:39177155 |
| GO:0004129 | Cytochrome-c oxidase activity | Decreases phenotype | PMID:25245570 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:23470461; PMID:25245570; PMID:29665407; PMID:30578656; PMID:39177155 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:28988497; PMID:29665407 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:23470461; PMID:25245570; PMID:28988497 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:23470461; PMID:25245570; PMID:28988497; PMID:31756458; PMID:35547012; PMID:36849043; PMID:39177155 |
| GO:0006089 | Lactate metabolic process | Increases phenotype | PMID:29665407 |
| GO:0006119 | Oxidative phosphorylation | Decreases phenotype | PMID:36473502 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:28988497; PMID:29665407; PMID:30578656; PMID:35547012; PMID:39177155 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:25245570; PMID:31756458 |
| GO:0006754 | Atp biosynthetic process | Affects phenotype | PMID:35435491 |
| GO:0006788 | Heme oxidation | Increases phenotype | PMID:29665407 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:23470461; PMID:25245570; PMID:30974164; PMID:35307491; PMID:36849043 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:31756458 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:25245570 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:18155343 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:32980475; PMID:36849043 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:30974164 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:28192182; PMID:30578656; PMID:30578656 |
| GO:0007588 | Excretion | Affects phenotype | PMID:18331393 |
| GO:0007613 | Memory | Affects phenotype | PMID:30090589 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:30090589 |
| GO:0008209 | Androgen metabolic process | Affects phenotype | PMID:33675932 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:33675932 |
| GO:0008219 | Cell death | Increases phenotype | PMID:26865462 |
| GO:0008253 | 5'-nucleotidase activity | Decreases phenotype | PMID:29665407 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:23718831; PMID:24962574 |
| GO:0008361 | Regulation of cell size | Affects phenotype | PMID:30315952 |
| GO:0008483 | Transaminase activity | Affects phenotype | PMID:30578656 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:33675932 |
| GO:0009261 | Ribonucleotide catabolic process | Decreases phenotype | PMID:29665407 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:30578656 |
| GO:0010923 | Negative regulation of phosphatase activity | Increases phenotype | PMID:30578656 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:23470461; PMID:28988497 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:36473502 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:18331393; PMID:29665407; PMID:39177155 |
| GO:0019853 | L-ascorbic acid biosynthetic process | Decreases phenotype | PMID:23470461 |
| GO:0022900 | Electron transport chain | Decreases phenotype | PMID:29665407 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:31756458 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:36931533 |
| GO:0032099 | Negative regulation of appetite | Increases phenotype | PMID:36416502 |
| GO:0032148 | Activation of protein kinase b activity | Decreases phenotype | PMID:26348139; PMID:36416502 |
| GO:0034109 | Homotypic cell-cell adhesion | Decreases phenotype | PMID:30315952 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:18331393; PMID:25409916; PMID:26348139; PMID:28192182; PMID:29665407; PMID:30578656; PMID:30578656; PMID:36416502; PMID:35547012; PMID:36416502; PMID:39177155 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:23470461 |
| GO:0035937 | Estrogen secretion | Decreases phenotype | PMID:23470461 |
| GO:0036211 | Protein modification process | Increases phenotype | PMID:35547012 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:28192182 |
| GO:0042110 | T cell activation | Decreases phenotype | PMID:28899767 |
| GO:0042130 | Negative regulation of t cell proliferation | Increases phenotype | PMID:28899767 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:30090589 |
| GO:0042701 | Progesterone secretion | Decreases phenotype | PMID:23470461 |
| GO:0042743 | Hydrogen peroxide metabolic process | Affects phenotype | PMID:32980475 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:25568306; PMID:26348139; PMID:26348139; PMID:32569804; PMID:37146930; PMID:37931768 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:29665407 |
| GO:0045821 | Positive regulation of glycolytic process | Increases phenotype | PMID:32569804 |
| GO:0046033 | Amp metabolic process | Increases phenotype | PMID:29665407 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:36849043 |
| GO:0046415 | Urate metabolic process | Decreases phenotype | PMID:18331393 |
| GO:0046449 | Creatinine metabolic process | Decreases phenotype | PMID:18331393; PMID:32980475 |
| GO:0046622 | Positive regulation of organ growth | Decreases phenotype | PMID:28192182 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:23470461 |
| GO:0050801 | Monoatomic ion homeostasis | Affects phenotype | PMID:30090589 |
| GO:0050860 | Negative regulation of t cell receptor signaling pathway | Affects phenotype | PMID:28899767 |
| GO:0050879 | Multicellular organismal movement | Decreases phenotype | PMID:36416502 |
| GO:0051348 | Negative regulation of transferase activity | Affects phenotype | PMID:30578656 |
| GO:0055072 | Iron ion homeostasis | Decreases phenotype | PMID:36416502 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:30315952 |
| GO:0061621 | Canonical glycolysis | Increases phenotype | PMID:36473502 |
| GO:0061739 | Protein lipidation involved in autophagosome assembly | Increases phenotype | PMID:32569804 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:28988497; PMID:28988497; PMID:30974164; PMID:31756458; PMID:39177155 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:36849043 |
| GO:0071243 | Cellular response to arsenic-containing substance | Affects phenotype | PMID:35547012 |
| GO:0071674 | Mononuclear cell migration | Increases phenotype | PMID:39177155 |
| GO:0072582 | 17-beta-hydroxysteroid dehydrogenase (nadp+) activity | Decreases phenotype | PMID:33675932 |
| GO:0102727 | 3beta-hydroxysteroid dehydrogenase activity | Decreases phenotype | PMID:33675932 |
| GO:1900111 | Positive regulation of histone h3-k9 dimethylation | Increases phenotype | PMID:29391238 |
| GO:1900113 | Negative regulation of histone h3-k9 trimethylation | Increases phenotype | PMID:37931768 |
| GO:1900114 | Positive regulation of histone h3-k9 trimethylation | Increases phenotype | PMID:29391238; PMID:37931768 |
| GO:1901666 | Positive regulation of nad+ adp-ribosyltransferase activity | Increases phenotype | PMID:18331393 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:30578656 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Affects phenotype | PMID:25409916; PMID:26348139; PMID:28192182 |
| GO:1901687 | Glutathione derivative biosynthetic process | Increases phenotype | PMID:29665407 |
| GO:1902093 | Positive regulation of flagellated sperm motility | Decreases phenotype | PMID:28192182 |
| GO:1902465 | Negative regulation of histone h3-k27 trimethylation | Increases phenotype | PMID:37931768 |
| GO:1902466 | Positive regulation of histone h3-k27 trimethylation | Increases phenotype | PMID:37931768 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:18331393; PMID:29665407; PMID:30578656 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Affects phenotype | PMID:25409916; PMID:26348139; PMID:28192182 |
| GO:1903407 | Negative regulation of p-type sodium:potassium-exchanging transporter activity | Increases phenotype | PMID:29665407 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:25409916; PMID:28192182; PMID:29665407; PMID:37146930 |
| GO:1904027 | Negative regulation of collagen fibril organization | Increases phenotype | PMID:37146930 |
| GO:1905709 | Negative regulation of membrane permeability | Increases phenotype | PMID:37146930 |
| GO:1905710 | Positive regulation of membrane permeability | Increases phenotype | PMID:37146930 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:36880428 |
| GO:2000355 | Negative regulation of ovarian follicle development | Increases phenotype | PMID:37931768 |
| GO:2000510 | Positive regulation of dendritic cell chemotaxis | Increases phenotype | PMID:24768652 |
| GO:2000738 | Positive regulation of stem cell differentiation | Increases phenotype | PMID:29391238 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:30578656 |
| GO:2000845 | Positive regulation of testosterone secretion | Decreases phenotype | PMID:28192182 |
| GO:2001057 | Reactive nitrogen species metabolic process | Increases phenotype | PMID:29665407 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.